Abbott Laboratories 615 Bond Debt To Equity

002819AC4   112.65  0.46  0.41%   
ABBOTT LABORATORIES 615 fundamentals help investors to digest information that contributes to ABBOTT's financial success or failures. It also enables traders to predict the movement of ABBOTT Bond. The fundamental analysis module provides a way to measure ABBOTT's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABBOTT bond.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ABBOTT LABORATORIES 615 Corporate Bond Debt To Equity Analysis

ABBOTT's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

According to the company disclosure, ABBOTT LABORATORIES 615 has a Debt To Equity of 0.0%. This indicator is about the same for the Manufacturing average (which is currently at 0.0) sector and about the same as Industrial (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).

ABBOTT Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABBOTT's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of ABBOTT could also be used in its relative valuation, which is a method of valuing ABBOTT by comparing valuation metrics of similar companies.
ABBOTT LABORATORIES cannot be rated in Debt To Equity category at this point.

About ABBOTT Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ABBOTT LABORATORIES 615's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABBOTT using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABBOTT LABORATORIES 615 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in ABBOTT Bond

ABBOTT financial ratios help investors to determine whether ABBOTT Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABBOTT with respect to the benefits of owning ABBOTT security.